Identifying and Managing the Patient with Moderate Psoriasis

This complimentary 6-part course will teach pharmacy professionals to identify people with moderate psoriasis who may need treatment escalation after a trial of topical agents.




This course has been designed to help community pharmacists identify people with moderate psoriasis who may need treatment escalation after a trial of topical agents. The course content reviews when systemic therapies are indicated and discusses the systemic treatment options available for moderate psoriasis. You will also learn how to monitor patients and help them manage common side effects with systemic therapies, to ensure ongoing adherence with treatment. This course includes six modules, accredited for 0.3 CEUs each. You can choose to do the first module only or continue in sequence to complete additional modules.

Note: this course is developed/conceived by Pear Healthcare Solutions/Health eLearning.

Learning objectives:

Module 1:

  • Discuss the prevalence of and triggers/risk factors for psoriasis.
  • Describe the symptoms of psoriasis, the different types of psoriasis, and which is most common.
  • Discuss the systemic nature of psoriasis and how it manifests throughout the body.


Module 2:

  • Differentiate between mild, moderate, and severe psoriasis
  • Describe the journey that the patient with moderate psoriasis may take in care
  • Determine when systemic therapy should be considered for a patient with psoriasis


Module 3:

  • List the topical treatment and phototherapy options used for psoriasis
  • Outline the types of conventional systemic agents for psoriasis
  • List the therapies used for more severe psoriasis, including biologics
  • Discuss when combination therapy is considered


Module 4:

  • Review considerations for the choice of systemic agent
  • Discuss baseline monitoring prior to starting systemic therapy for the different types of agents
  • Review special considerations for biologic drugs
  • Outline other counselling considerations for systemic therapies (e.g., vaccinations, surgery)


Module 5:

  • Discuss adverse effects that can occur with the different types of systemic therapy for psoriasis
  • Review management strategies for adverse effects
  • Describe counselling approaches to support patients with adverse effect management


Module 6:

  • Discuss ongoing monitoring parameters for patients taking systemic therapies for psoriasis
  • Review when and how to follow up with patients with psoriasis
  • Outline approaches to take to encourage persistence with therapy

Course outline:

  • Module 1:
    Psoriasis: A Systemic Disease
  • Module 2:
    Moderate Psoriasis: The Patient Journey
  • Module 3:
    Treatment Options for Moderate Psoriasis
  • Module 4:
    Initiating Systemic Therapy for Psoriasis
  • Module 5:
    Adverse Effect Management
  • Module 6:
    Monitoring the Patient with Moderate Psoriasis


This course has been supported by an educational grant from Amgen.

Course at a glance:

  • 1.5 Hours to complete
  • 1.8 CEUs
  • Available until July 15, 2021
  • Online
  • Accreditation: 1057-2020-3032-I-P
  • Completion requirement: Complete the course modules and the assessment to complete the course and earn the CCCEP credits.

Who should take this course:


Development Team:

  • Rosemarie Patodia, BScPhm, CGP
  • Carolyn Whiskin, RPh, BScPhm, NCP
  • Cameron Bonell, BSc(Pharm) ACPR RPh
  • Marvin Ng, BSc, PharmD


  • One of the subject matter experts wishes to disclose that she is the Editorial Director at Pear Healthcare Solutions. The second subject matter expert wishes to disclose that she is a member of advisory boards, received honorarium, and is a paid speaker for commercial entities including the sponsor.

  • One of the reviewers wishes to disclose that he has participated on advisory boards, was a paid speaker and received honoraria from commercial entities other than this one.